Table 3.
Outcome Distribution by RAS Groups in Matched Cohort
| No RASi (N = 579) | ARBs (N = 193) | ACEi (N = 579) | Total (N = 1351) | |
|---|---|---|---|---|
| Major Periop Adverse Outcome | 219 (37.82%) | 70 (36.27%) | 235 (40.59%) | 524 (38.79%) |
| Pt died on or before 30 days | 4 (0.69%) | 0 (0.00%) | 10 (1.73%) | 14 (1.04%) |
| Peri-index CABG MI | 60 (10.36%) | 18 (9.33%) | 58 (10.02%) | 136 (10.07%) |
| Re-intubation | 17 (2.94%) | 6 (3.11%) | 18 (3.11%) | 41 (3.03%) |
| Any AFIB/Flutter AE | 144 (24.87%) | 48 (24.87%) | 163 (28.15%) | 355 (26.28%) |
| Any Renal Failure AE | 40 (6.91%) | 12 (6.22%) | 47 (8.12%) | 99 (7.33%) |
| Any CVA/TIA AE | 10 (1.73%) | 4 (2.07%) | 11 (1.90%) | 25 (1.85%) |
| Cardioversion | 9 (1.55%) | 0 (0.00%) | 15 (2.59%) | 24 (1.78%) |
| Dialysis | 4 (0.69%) | 0 (0.00%) | 6 (1.04%) | 10 (0.74%) |